Isolated Acquired Macrodactyly of the Left Fourth Toe

por Alexander, Leon, El Kazzaz, Ahmed Mohamed H., Schenker, Michael
Publicado 2021

Role of combining neutrophil-to-lymphocyte ratio and pretreatment body mass index in predicting progression-free survival in patients with non-small cell lung cancer treated with n...

por Dragomir, Radu, Dragomir, Adelina Silvana, Negru, Alina, Săftescu, Sorin, Popovici, Dorel, Schenker, Michael, Lupușoru, Raluca, Negru, Șerban
Publicado 2021

The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma

por Ciurea, Ana-Maria, Gheonea, Dan Ionuț, Schenker, Michael, Mehedințeanu, Alina Maria, Târtea, Georgică Costinel, Vere, Cristin Constantin
Publicado 2021

Assessment of Epinephrine and Norepinephrine in Gastric Carcinoma

por Mehedințeanu, Alina Maria, Sfredel, Veronica, Stovicek, Puiu Olivian, Schenker, Michael, Târtea, Georgică Costinel, Istrătoaie, Octavian, Ciurea, Ana-Maria, Vere, Cristin Constantin
Publicado 2021

Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review

por Mireștean, Camil Ciprian, Stan, Mihai Cosmin, Schenker, Michael, Volovăț, Constantin, Volovăț, Simona Ruxandra, Iancu, Dragoș Teodor Petru, Iancu, Roxana Irina, Bădulescu, Florinel
Publicado 2023

Evaluation of Hepatocellular Carcinoma Patients: Interim Analysis of Cases from a Tertiary Referral Center in Craiova, Romania

por CIUREA, ANA-MARIA, VERE, CRISTIN CONSTANTIN, SCHENKER, MICHAEL, GHEONEA, IOANA ANDREEA, STREBA, LILIANA, SĂNDULESCU, LARISA DANIELA, MEHEDINŢEANU, ALINA MARIA, GHEONEA, DAN-IONUŢ
Publicado 2021

E-cadherin and aquaporin 1 co-expression analysis in hepatocellular carcinoma: a pilot study

por Ciurea, Ana-Maria, Vere, Cristin Constantin, Popp, Cristiana Gabriela, Streba, Costin Teodor, Caliţa, Mihaela, Pirici, Daniel, Cercelaru, Liliana, Schenker, Michael, Gheonea, Dan Ionuţ, Pirici, Ionica
Publicado 2021

Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study

por Thongprasert, Sumitra, Geater, Sarayut L, Clement, Dana, Abdelaziz, Amr, Reyes-Igama, Jasmin, Jovanovic, Dragana, Alexandru, Aurelia, Schenker, Michael, Sriuranpong, Virote, Serwatowski, Piotr, Suresh, Sheethal, Cseh, Agnieszka, Gaafar, Rabab
Publicado 2019

Expression of M3 muscarinic acetylcholine receptors in gastric cancer

por Mehedinţeanu, Alina Maria, Mirea, Cecil Sorin, Stovicek, Puiu Olivian, Schenker, Michael, Stancu, Marius Ionuţ, Ciurea, Ana-Maria, Streba, Liliana, Istrate-Ofiţeru, Anca-Maria, Sas, Teodor-Nicuşor, Vere, Cristin Constantin
Publicado 2021

Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial

por Lim, Sun Min, Peters, Solange, Ortega Granados, Ana Laura, Pinto, Gustavo dix Junqueira, Fuentes, Christian Sebastián, Lo Russo, Giuseppe, Schenker, Michael, Ahn, Jin Seok, Reck, Martin, Szijgyarto, Zsolt, Huseinovic, Neda, Zografos, Eleftherios, Buss, Elena, Stjepanovic, Neda, O’Donnell, Sean, de Marinis, Filippo
Publicado 2023

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the mona...

por Martin, Miguel, Hegg, Roberto, Kim, Sung-Bae, Schenker, Michael, Grecea, Daniela, Garcia-Saenz, Jose Angel, Papazisis, Konstantinos, Ouyang, QuChang, Lacko, Aleksandra, Oksuzoglu, Berna, Reeves, James, Okera, Meena, Testa, Laura, Shimizu, Chikako, Denduluri, Neelima, Adamchuk, Hryhoriy, Dakhil, Shaker, Wei, Ran, Forrester, Tammy, Fernandez, Maria Munoz, Zimmermann, Annamaria, Headley, Desiree, Johnston, Stephen R. D.
Publicado 2022

Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714...

por Harrington, Kevin J., Ferris, Robert L., Gillison, Maura, Tahara, Makoto, Argiris, Athanasios, Fayette, Jérôme, Schenker, Michael, Bratland, Åse, Walker, John W. T., Grell, Peter, Even, Caroline, Chung, Christine H., Redman, Rebecca, Coutte, Alexandre, Salas, Sébastien, Grant, Cliona, de Azevedo, Sergio, Soulières, Denis, Hansen, Aaron R., Wei, Li, Khan, Tariq Aziz, Miller-Moslin, Karen, Roberts, Mustimbo, Haddad, Robert
Publicado 2023

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

por Owonikoko, Taofeek K., Park, Keunchil, Govindan, Ramaswamy, Ready, Neal, Reck, Martin, Peters, Solange, Dakhil, Shaker R., Navarro, Alejandro, Rodríguez-Cid, Jerónimo, Schenker, Michael, Lee, Jong-Seok, Gutierrez, Vanesa, Percent, Ivor, Morgensztern, Daniel, Barrios, Carlos H., Greillier, Laurent, Baka, Sofia, Patel, Miten, Lin, Wen Hong, Selvaggi, Giovanni, Baudelet, Christine, Baden, Jonathan, Pandya, Dimple, Doshi, Parul, Kim, Hye Ryun
Publicado 2021

Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results

por Diab, Adi, Gogas, Helen, Sandhu, Shahneen, Long, Georgina V., Ascierto, Paolo A., Larkin, James, Sznol, Mario, Franke, Fabio, Ciuleanu, Tudor E., Pereira, Caio, Muñoz Couselo, Eva, Bronzon Damian, Fernanda, Schenker, Michael, Perfetti, Aldo, Lebbe, Celeste, Quéreux, Gaëlle, Meier, Friedegund, Curti, Brendan D., Rojas, Carlos, Arriaga, Yull, Yang, Haisu, Zhou, Ming, Ravimohan, Shruthi, Statkevich, Paul, Tagliaferri, Mary A., Khushalani, Nikhil I.
Publicado 2023

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

por Mandalá, Mario, Larkin, James, Ascierto, Paolo A, Del Vecchio, Michele, Gogas, Helen, Cowey, C Lance, Arance, Ana, Dalle, Stéphane, Schenker, Michael, Grob, Jean-Jacques, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Butler, Marcus O, Di Giacomo, Anna Maria, Lutzky, Jose, De La Cruz-Merino, Luis, Atkinson, Victoria, Arenberger, Petr, Hill, Andrew, Fecher, Leslie, Millward, Michael, Khushalani, Nikhil I, de Pril, Veerle, Lobo, Maurice, Weber, Jeffrey
Publicado 2021

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

por Shitara, Kohei, Ajani, Jaffer A., Moehler, Markus, Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Bragagnoli, Arinilda Campos, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Bruges, Ricardo, Zander, Thomas, de Azevedo, Sergio, Kowalyszyn, Ruben, Pazo-Cid, Roberto, Schenker, Michael, Cleary, James M., Yanez, Patricio, Feeney, Kynan, Karamouzis, Michalis V., Poulart, Valerie, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Janjigian, Yelena Y.
Publicado 2022

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Cli...

por Schmid, Peter, Zaiss, Matthias, Harper-Wynne, Catherine, Ferreira, Marta, Dubey, Sidharth, Chan, Stephen, Makris, Andreas, Nemsadze, Gia, Brunt, Adrian M., Kuemmel, Sherko, Ruiz, Isabel, Perelló, Antonia, Kendall, Anne, Brown, Janet, Kristeleit, Hartmut, Conibear, John, Saura, Cristina, Grenier, Julien, Máhr, Károly, Schenker, Michael, Sohn, Joohyuk, Lee, Keun Seok, Shepherd, Christopher J., Oelmann, Elisabeth, Sarker, Shah-Jalal, Prendergast, Aaron, Marosics, Patricia, Moosa, Atiyyah, Lawrence, Cheryl, Coetzee, Carike, Mousa, Kelly, Cortés, Javier
Publicado 2019

Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarc...

por Shah, Manish A., Udrea, Anghel Adrian, Bondarenko, Igor, Mansoor, Was, Sánchez, Raquel Guardeño, Sarosiek, Tomasz, Bozzarelli, Silvia, Schenker, Michael, Gomez-Martin, Carlos, Morgan, Carys, Özgüroğlu, Mustafa, Pikiel, Joanna, Kalofonos, Haralabos P., Wojcik, Elzbieta, Buchler, Tomas, Swinson, Daniel, Cicin, Irfan, Joseph, Mano, Vynnychenko, Ihor, Luft, Alexander Valerievich, Enzinger, Peter C., Salek, Tomas, Papandreou, Christos, Tournigand, Christophe, Maiello, Evaristo, Wei, Ran, Ferry, David, Gao, Ling, Oliveira, Joana M., Ajani, Jaffer A.
Publicado 2022

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238

por Larkin, James, Del Vecchio, Michele, Mandalá, Mario, Gogas, Helen, Arance Fernandez, Ana M., Dalle, Stéphane, Cowey, Charles Lance, Schenker, Michael, Grob, Jean-Jacques, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Butler, Marcus O., Di Giacomo, Anna Maria, Middleton, Mark R., Lutzky, Jose, de la Cruz-Merino, Luis, Arenberger, Petr, Atkinson, Victoria, Hill, Andrew G., Fecher, Leslie A., Millward, Michael, Nathan, Paul D., Khushalani, Nikhil I., Queirolo, Paola, Ritchings, Corey, Lobo, Maurice, Askelson, Margarita, Tang, Hao, Dolfi, Sonia, Ascierto, Paolo A., Weber, Jeffrey
Publicado 2023

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

por Monk, Bradley J., Parkinson, Christine, Lim, Myong Cheol, O'Malley, David M., Oaknin, Ana, Wilson, Michelle K., Coleman, Robert L., Lorusso, Domenica, Bessette, Paul, Ghamande, Sharad, Christopoulou, Athina, Provencher, Diane, Prendergast, Emily, Demirkiran, Fuat, Mikheeva, Olga, Yeku, Oladapo, Chudecka-Glaz, Anita, Schenker, Michael, Littell, Ramey D., Safra, Tamar, Chou, Hung-Hsueh, Morgan, Mark A., Drochýtek, Vít, Barlin, Joyce N., Van Gorp, Toon, Ueland, Fred, Lindahl, Gabriel, Anderson, Charles, Collins, Dearbhaile C., Moore, Kathleen, Marme, Frederik, Westin, Shannon N., McNeish, Iain A., Shih, Danny, Lin, Kevin K., Goble, Sandra, Hume, Stephanie, Fujiwara, Keiichi, Kristeleit, Rebecca S.
Publicado 2022